The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

The course of COVID-19 infection may be complicated by a variety of neurological
manifestations. Since the inner ear is vulnerable to viruses, sensorineural hearing loss …

Background Tixagevimab and cilgavimab, a combined monoclonal antibody (Evusheld),
was granted emergency use authorization for severe acute respiratory syndrome …

(1) Background: Vaccine safety is an important topic with public health implications on a
global scale. The purpose of this study was to systematically review available literature …

Importance Spontaneous adverse reaction reports of sudden hearing loss have been
observed, and a population-based cohort study conducted in Israel showed an increase in …

Background: The World Health Organization recently described sudden sensorineural
hearing loss (SSNHL) as a possible adverse effect of COVID-19 vaccines. Recent …

Coronavirus disease 2019 (COVID-19) was declared a pandemic due to its rapid spread
worldwide, and its vaccination campaign is considered one of the most historic public …

Background Atrial fibrillation (AF) is associated with substantial morbidity and mortality. New-
onset AF (NOAF) has been related recently to SARS-CoV-2 infection; however, the evidence …

Virus infection is one of the most common etiologies of hearing loss. Hearing loss
associated with viral infection can be unilateral or bilateral, mild or severe, sudden or …

Objective To compare the occurrence of sudden sensorineural hearing loss following
immunization with BNT162b2 (Comirnaty®; Pfizer BioNTech) or mRNA‐1273 (Spikevax®; …